Core Viewpoint - Fosun Pharma has successfully completed the issuance of its second phase of technology innovation bonds for the year 2025, indicating a strategic move to raise funds for innovation and development [1] Group 1 - The company issued a total of 1 billion RMB in bonds, with a maturity period of 2 years [1] - The bonds are priced at 100 RMB per 100 RMB face value, with an interest rate of 2.70% [1]